In September 2015 Clinigen (CLIN) acquired specialist pharmaceutical and medical technology business Link Healthcare. Link's chairman, John Bacon, joined Clinigen's board and, along with all Link shareholders, was allotted Clinigen shares at a value of 721p - the mid-market price for the 10 days of trading leading up to the acquisition. But Mr Bacon has now sold down that holding, cashing in almost £1.5m in the process. According to a spokesperson for the company, Mr Bacon is "rationalising his personal assets". But by selling at 717p he's made a loss here.
Apart from the brief blip when Mr Bacon made his sale, Clinigen shares have been riding high as the group continues to sign up more licensing deals. The Link acquisition has been instrumental to the group's expansion in Africa, Asia and Australia and in October it launched a Japanese business as well.
| Buys | |||||||
|---|---|---|---|---|---|---|---|
| Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
| 3i | Jonathan Asquith | 11 Nov 16 | 26,000 | 617 | 160,420 | 40,001 | 0.004 |
| BATM Advanced Communications | Gideon Chitayat (ch) | 10 Nov 16 | 1,000,000 | 15.5 | 155,000 | 3,000,000 | 0.744 |
| Burberry | Carolyn McCall | 10 Nov 16 | 1,368 | 1449.47 | 19,829 | 2,535 | 0.001 |
| CVS♥ | Simon Innes (ce) | 15 Nov 16 | 5,750 | 867 | 49,853 | 252,225 | 0.418 |
| Carclo | Michael Derbyshire (ch) | 16 Nov 16 | 10,000 | 124.75 | 12,475 | 70,000 | 0.096 |
| Carclo | Robert Rickman | 16 Nov 16 | 10,000 | 122.25 | 12,225 | 15,300 | 0.021 |
| Computacenter | Gregory Lock (ch) | 10 Nov 16 | 800 | 736 | 5,888 | 565,400 | 0.461 |
| Computacenter | Gregory Lock (ch) | 10 Nov 16 | 4,000 | 718.5 | 28,740 | 564,600 | 0.460 |
| Computacenter | Gregory Lock (ch) | 11 Nov 16 | 6,000 | 720 | 43,200 | 571,400 | 0.466 |
| Computacenter | Gregory Lock (ch) | 14 Nov 16 | 10,000 | 721 | 72,100 | 581,400 | 0.474 |
| Computacenter | Gregory Lock (ch) | 15 Nov 16 | 5,000 | 721 | 36,050 | 586,400 | 0.478 |
| Devro | Gerard Hoetmer (ch) | 10 Nov 16 | 15,000 | 178 | 26,700 | 90,000 | 0.054 |
| Devro | Paul Withers | 14 Nov 16 | 20,000 | 182.801 | 36,560 | 110,000 | 0.066 |
| Devro♥ | Paul Neep | 10 Nov 16 | 4,000 | 189.4686 | 7,579 | 224,893 | 0.135 |
| Devro | Peter Page (ceo) | 10 Nov 16 | 8,300 | 180.6875 | 14,997 | 690,740 | 0.414 |
| Diageo | J Ferran | 15 Nov 16 | 13,000 | 1975 | 256,750 | 31,500 | 0.001 |
| Gocompare.com | Angela Seymour-Jackson | 14 Nov 16 | 36,973 | 66.975 | 24,763 | 36,973 | 0.009 |
| Grafenia | Peter Gunning (ceo) | 16 Nov 16 | 250,000 | 8 | 20,000 | 1,250,000 | 2.753 |
| Henderson Opportunities Trust | Peter Jones (ch) | 15 Nov 16 | 2,500 | 790.58 | 19,765 | 10,000 | 0.125 |
| Henderson Smaller Companies Investment Trust | Victoria Sant | 14 Nov 16 | 500 | 622 | 3,110 | 500 | 0.001 |
| Huntsworth | Paul Taaffe (ceo) | 10 Nov 16 | 100,000 | 40 | 40,000 | 400,000 | 0.122 |
| Hydrogen | Richard Green | 15 Nov 16 | 166,666 | 30 | 50,000 | 166,666 | 0.697 |
| Informa | Helen Owers | 16 Nov 16 | 1,163 | 635.3838 | 7,390 | 3,663 | 0.000 |
| JPMorgan Mid Cap Investment Trust | Michael Hughes (ch) | 11 Nov 16 | 5,000 | 886.615 | 44,331 | 9,000 | 0.038 |
| Kennedy Wilson Europe Real Estate | Simon Radford | 11 Nov 16 | 3,300 | 1017 | 33,561 | 12,500 | 0.010 |
| Marks & Spencer | Patrick Bousquet-Chavanne | 14 Nov 16 | 2,000 | 336.0677 | 6,721 | 120,398 | 0.007 |
| Marks & Spencer | Patrick Bousquet-Chavanne | 15 Nov 16 | 2,700 | 341.984 | 9,234 | 123,098 | 0.008 |
| Menzies (John) | Geoff Eaton | 14 Nov 16 | 4,000 | 494.75 | 19,790 | 4,000 | 0.005 |
| Non-Standard Finance | Charles Gregson | 15 Nov 16 | 9,000 | 56.88 | 5,119 | 256,083 | 0.081 |
| Oakley Capital Investments | Peter Dubens | 11 Nov 16 | 250,000 | 150.25 | 375,625 | 1,660,000 | 0.875 |
| Ocado | Alex Mahon | 10 Nov 16 | 6,256 | 271.7 | 16,998 | 17,355 | 0.003 |
| Octagonal | Martin Davison | 16 Nov 16 | 1,500,000 | 1.8 | 27,000 | 18,265,000 | 3.260 |
| Picton Property Income | Roger Lewis | 16 Nov 16 | 70,000 | 74.208 | 51,946 | 600,000 | 0.111 |
| Quantum Pharma* | Chris Rigg (ceo & cfo) | 11 Nov 16 | 147,059 | 34 | 50,000 | 162,059 | 0.096 |
| Quantum Pharma* | John Brown | 11 Nov 16 | 73,529 | 34 | 25,000 | 73,529 | 0.043 |
| Quantum Pharma* | Ian Johnson (ch) | 11 Nov 16 | 58,824 | 34 | 20,000 | 58,824 | 0.035 |
| RELX | Wolfhart Hauser | 16 Nov 16 | 7,435 | 1337.99 | 99,480 | 11,542 | 0.001 |
| SIG | Janet Ashdown | 14 Nov 16 | 11,000 | 91 | 10,010 | 44,450 | 0.008 |
| SIG | Mel Ewell | 15 Nov 16 | 11,000 | 89.65 | 9,862 | 27,450 | 0.005 |
| SSE | Katie Bickerstaffe | 16 Nov 16 | 677 | 1460 | 9,884 | 6,433 | 0.001 |
| SSE | Katie Bickerstaffe | 16 Nov 16 | 677 | 1461 | 9,891 | 5,756 | 0.001 |
| Science in Sport | Stephen Moon (ceo) | 15 Nov 16 | 10,000 | 62 | 6,200 | 726,313 | 1.681 |
| Science in Sport | Stephen Moon (ceo) | 16 Nov 16 | 10,000 | 63 | 6,300 | 736,313 | 1.704 |
| Speedy Hire | David Shearer | 16 Nov 16 | 100,000 | 42.5 | 42,500 | 100,000 | 0.019 |
| Standard Life Investments Property Income Trust | Michael Balfour | 16 Nov 16 | 24,000 | 86.5 | 20,760 | 24,000 | 0.006 |
| Stock Spirits | Michael Butterworth | 14 Nov 16 | 18,750 | 160 | 30,000 | 18,750 | 0.009 |
| Vodafone | Valerie Gooding | 15 Nov 16 | 16,970 | 206.24 | 34,999 | 28,970 | 0.000 |
| Sells | |||||||
|---|---|---|---|---|---|---|---|
| Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
| Clinigen | John Bacon | 11 Nov 16 | 200,000 | 717 | 1,434,000 | 730,767 | 0.635 |
| * placing/tender/open offer ♥ spouse/connected party | |||||||
